ACS Publications. Most Trusted. Most Cited. Most Read
My Activity
CONTENT TYPES

Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia

View Author Information
Departments of Medicinal Chemistry
Chemistry Modeling and Informatics
§ In Vitro Sciences
Depression and Circadian Disorders
Drug Metabolism
Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486
*To whom correspondence should be addressed. Phone: + 1-215-652-2411. Fax: + 1-215-652-7310. E-mail: [email protected]
Cite this: J. Med. Chem. 2010, 53, 14, 5320–5332
Publication Date (Web):June 21, 2010
https://doi.org/10.1021/jm100541c
Copyright © 2010 American Chemical Society

    Article Views

    10694

    Altmetric

    -

    Citations

    LEARN ABOUT THESE METRICS
    Other access options
    Supporting Info (1)»

    Abstract

    Abstract Image

    Despite increased understanding of the biological basis for sleep control in the brain, few novel mechanisms for the treatment of insomnia have been identified in recent years. One notable exception is inhibition of the excitatory neuropeptides orexins A and B by design of orexin receptor antagonists. Herein, we describe how efforts to understand the origin of poor oral pharmacokinetics in a leading HTS-derived diazepane orexin receptor antagonist led to the identification of compound 10 with a 7-methyl substitution on the diazepane core. Though 10 displayed good potency, improved pharmacokinetics, and excellent in vivo efficacy, it formed reactive metabolites in microsomal incubations. A mechanistic hypothesis coupled with an in vitro assay to assess bioactivation led to replacement of the fluoroquinazoline ring of 10 with a chlorobenzoxazole to provide 3 (MK-4305), a potent dual orexin receptor antagonist that is currently being tested in phase III clinical trials for the treatment of primary insomnia.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Supporting Information

    ARTICLE SECTIONS
    Jump To

    Experimental procedures for compounds 813, as well as reproductions of the 1H and 13C NMR spectra for key compounds. This material is available free of charge via the Internet at http://pubs.acs.org.

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    This article is cited by 313 publications.

    1. Jodi T. Williams, Martin H. Bolli, Christine Brotschi, Thierry Sifferlen, Michel A. Steiner, Alexander Treiber, John Gatfield, Christoph Boss. Discovery of Nivasorexant (ACT-539313): The First Selective Orexin-1 Receptor Antagonist (SO1RA) Investigated in Clinical Trials. Journal of Medicinal Chemistry 2024, 67 (4) , 2337-2348. https://doi.org/10.1021/acs.jmedchem.3c01894
    2. Jian Rong, Tomoteru Yamasaki, Yinlong Li, Katsushi Kumata, Chunyu Zhao, Ahmed Haider, Jiahui Chen, Zhiwei Xiao, Masayuki Fujinaga, Kuan Hu, Wakana Mori, Yiding Zhang, Lin Xie, Xin Zhou, Thomas L. Collier, Ming-Rong Zhang, Steven Liang. Development of Novel 11C-Labeled Selective Orexin-2 Receptor Radioligands for Positron Emission Tomography Imaging. ACS Medicinal Chemistry Letters 2023, 14 (10) , 1419-1426. https://doi.org/10.1021/acsmedchemlett.3c00320
    3. Lipeng Long, Xin Li, Yu Wang, Xing Su, Liang Qiao, Wenjun Luo, Zhengwang Chen. Cobalt-Catalyzed Hypervalent Iodine(III) Promoted Cascade Annulation Reaction of Anilines with Formamides for 2-Aminobenzoxazoles Synthesis. The Journal of Organic Chemistry 2023, 88 (11) , 7571-7579. https://doi.org/10.1021/acs.joc.3c00547
    4. Edna Mao, David W.C. MacMillan. Late-Stage C(sp3)–H Methylation of Drug Molecules. Journal of the American Chemical Society 2023, 145 (5) , 2787-2793. https://doi.org/10.1021/jacs.2c13396
    5. Nicholas A. Meanwell, Olivier Loiseleur. Applications of Isosteres of Piperazine in the Design of Biologically Active Compounds: Part 2. Journal of Agricultural and Food Chemistry 2022, 70 (36) , 10972-11004. https://doi.org/10.1021/acs.jafc.2c00729
    6. Bei Zhang, Jinhang Yu, Xin Wu, Zeyu Chai, Guoying Zhao, Zihan Li, Honglan Kang, Xin Lv, Liejin Zhou. Synthesis of Furo[2,3-e][1,4]diazepin-3-one Derivatives through Tandem Cyclization/[4 + 3] Annulation Reactions. The Journal of Organic Chemistry 2022, 87 (5) , 3668-3676. https://doi.org/10.1021/acs.joc.1c02561
    7. Uta Lessel, Marco Ferrara, Niklas Heine, Chiara Marelli, Laura Carrettoni, Roland Pfau, Esther Schmidt, Doris Riether. Identification of Highly Selective Orexin 1 Receptor Antagonists Driven by Structure-Based Design. Journal of Chemical Information and Modeling 2021, 61 (12) , 5893-5905. https://doi.org/10.1021/acs.jcim.1c01055
    8. Yulei Wang, Zhipeng Lin, João C. A. Oliveira, Lutz Ackermann. Electro-oxidative Intermolecular Allylic C(sp3)–H Aminations. The Journal of Organic Chemistry 2021, 86 (22) , 15935-15945. https://doi.org/10.1021/acs.joc.1c00682
    9. Jingwen Liang, Yingqi Rao, Weidong Zhu, Tingting Wen, Junjie Huang, Zhichao Chen, Lu Chen, Yibiao Li, Xiuwen Chen, Zhongzhi Zhu. AgNO3 as Nitrogen Source for Cu-Catalyzed Cyclization of Oximes with Isocyanates: A Facile Route to N-2-Aryl-1,2,3-triazoles. Organic Letters 2021, 23 (18) , 7028-7032. https://doi.org/10.1021/acs.orglett.1c02323
    10. Fang-Fang Feng, Jun-Kuan Li, Xuan-Yu Liu, Fa-Guang Zhang, Chi Wai Cheung, Jun-An Ma. General Synthesis of Tri-Carbo-Substituted N2-Aryl-1,2,3-triazoles via Cu-Catalyzed Annulation of Azirines with Aryldiazonium Salts. The Journal of Organic Chemistry 2020, 85 (16) , 10872-10883. https://doi.org/10.1021/acs.joc.0c01433
    11. Zefei Xu, Peiyuan Yao, Xiang Sheng, Jinlong Li, Jianjiong Li, Shanshan Yu, Jinhui Feng, Qiaqing Wu, Dunming Zhu. Biocatalytic Access to 1,4-Diazepanes via Imine Reductase-Catalyzed Intramolecular Asymmetric Reductive Amination. ACS Catalysis 2020, 10 (15) , 8780-8787. https://doi.org/10.1021/acscatal.0c02400
    12. Gunasekaran Balamurugan, Rengan Ramesh, Jan Grzegorz Malecki. Nickel(II)–NΛNΛO Pincer Type Complex-Catalyzed N-alkylation of Amines with Alcohols via the Hydrogen Autotransfer Reaction. The Journal of Organic Chemistry 2020, 85 (11) , 7125-7135. https://doi.org/10.1021/acs.joc.0c00530
    13. Mathieu Rappas, Ammar A. E. Ali, Kirstie A. Bennett, Jason D. Brown, Sarah J. Bucknell, Miles Congreve, Robert M. Cooke, Gabriella Cseke, Chris de Graaf, Andrew S. Doré, James C. Errey, Ali Jazayeri, Fiona H. Marshall, Jonathan S. Mason, Richard Mould, Jayesh C. Patel, Benjamin G. Tehan, Malcolm Weir, John A. Christopher. Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis. Journal of Medicinal Chemistry 2020, 63 (4) , 1528-1543. https://doi.org/10.1021/acs.jmedchem.9b01787
    14. Jason M. Uslaner, William J. Herring, Paul J. Coleman. The Discovery of Suvorexant: Lessons Learned That Can Be Applied to Other CNS Drug Development Efforts. ACS Pharmacology & Translational Science 2020, 3 (1) , 161-168. https://doi.org/10.1021/acsptsci.9b00110
    15. Oleg I. Afanasyev, Ekaterina Kuchuk, Dmitry L. Usanov, Denis Chusov. Reductive Amination in the Synthesis of Pharmaceuticals. Chemical Reviews 2019, 119 (23) , 11857-11911. https://doi.org/10.1021/acs.chemrev.9b00383
    16. Pengli Bao, Huilan Yue, Na Meng, Xiaohui Zhao, Jiangsheng Li, Wei Wei. Copper-Catalyzed Three-Component Reaction of Alkynes, TMSN3, and Ethers: Regiocontrollable Synthesis of N1- and N2-Oxyalkylated 1,2,3-Triazoles. Organic Letters 2019, 21 (18) , 7218-7222. https://doi.org/10.1021/acs.orglett.9b02295
    17. Dingyuan Yan, Heming Jiang, Wenxue Sun, Wei Wei, Jing Zhao, Xinhao Zhang, Yun-Dong Wu. Synthesis of Benzofurans and Benzoxazoles through a [3,3]-Sigmatropic Rearrangement: O–NHAc as a Multitasking Functional Group. Organic Process Research & Development 2019, 23 (8) , 1646-1653. https://doi.org/10.1021/acs.oprd.9b00002
    18. Sahar Roshandel, Maiko J. Lunn, Golam Rasul, Daniel Sylvinson Muthiah Ravinson, Suresh C. Suri, G. K. Surya Prakash. Catalyst-Free Regioselective N2 Arylation of 1,2,3-Triazoles Using Diaryl Iodonium Salts. Organic Letters 2019, 21 (16) , 6255-6258. https://doi.org/10.1021/acs.orglett.9b02140
    19. Mookda Pattarawarapan, Dolnapa Yamano, Nitaya Wiriya, Wong Phakhodee. Metal-Free Synthesis of 2-N,N-Dialkylaminobenzoxazoles Using Tertiary Amines as the Nitrogen Source. The Journal of Organic Chemistry 2019, 84 (10) , 6516-6523. https://doi.org/10.1021/acs.joc.9b00797
    20. Lasse Karhu, Aniket Magarkar, Alex Bunker, Henri Xhaard. Determinants of Orexin Receptor Binding and Activation—A Molecular Dynamics Study. The Journal of Physical Chemistry B 2019, 123 (12) , 2609-2622. https://doi.org/10.1021/acs.jpcb.8b10220
    21. Russell T. Smith, Xiaheng Zhang, Juan A. Rincón, Javier Agejas, Carlos Mateos, Mario Barberis, Susana García-Cerrada, Oscar de Frutos, David W. C. MacMillan. Metallaphotoredox-Catalyzed Cross-Electrophile Csp3–Csp3 Coupling of Aliphatic Bromides. Journal of the American Chemical Society 2018, 140 (50) , 17433-17438. https://doi.org/10.1021/jacs.8b12025
    22. Hong-Xia Wang, Tian-Qi Wei, Pei Xu, Shun-Yi Wang, Shun-Jun Ji. I2/TBHP-Mediated Oxidative Coupling of Amino-Based Bisnucleophiles and Isocyanides: Access to 2-Aminobenzoxazinones, 2-Aminobenzoxazines, and 2-Aminoquinazolines under Metal-Free Conditions. The Journal of Organic Chemistry 2018, 83 (21) , 13491-13497. https://doi.org/10.1021/acs.joc.8b02395
    23. Eakkaphon Rattanangkool, Mongkol Sukwattanasinitt, and Sumrit Wacharasindhu . Organocatalytic Visible Light Enabled SNAr of Heterocyclic Thiols: A Metal-Free Approach to 2-Aminobenzoxazoles and 4-Aminoquinazolines. The Journal of Organic Chemistry 2017, 82 (24) , 13256-13262. https://doi.org/10.1021/acs.joc.7b02357
    24. Hiroshi Nagase, Naoshi Yamamoto, Masahiro Yata, Sayaka Ohrui, Takahiro Okada, Tsuyoshi Saitoh, Noriki Kutsumura, Yasuyuki Nagumo, Yoko Irukayama-Tomobe, Yukiko Ishikawa, Yasuhiro Ogawa, Shigeto Hirayama, Daisuke Kuroda, Yurie Watanabe, Hiroaki Gouda, and Masashi Yanagisawa . Design and Synthesis of Potent and Highly Selective Orexin 1 Receptor Antagonists with a Morphinan Skeleton and Their Pharmacologies. Journal of Medicinal Chemistry 2017, 60 (3) , 1018-1040. https://doi.org/10.1021/acs.jmedchem.6b01418
    25. Roy P. Lester, Travis Bham, Thomas W. Bousfield, William Lewis, and Jason E. Camp . Exploring the Reactivity of 2-Trichloromethylbenzoxazoles for Access to Substituted Benzoxazoles. The Journal of Organic Chemistry 2016, 81 (24) , 12472-12477. https://doi.org/10.1021/acs.joc.6b02315
    26. Tanaji T. Talele . The “Cyclopropyl Fragment” is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules. Journal of Medicinal Chemistry 2016, 59 (19) , 8712-8756. https://doi.org/10.1021/acs.jmedchem.6b00472
    27. Ainoleena Turku, Alexandre Borrel, Teppo O. Leino, Lasse Karhu, Jyrki P. Kukkonen, and Henri Xhaard . Pharmacophore Model To Discover OX1 and OX2 Orexin Receptor Ligands. Journal of Medicinal Chemistry 2016, 59 (18) , 8263-8275. https://doi.org/10.1021/acs.jmedchem.6b00333
    28. Li-Li Zhu, Xiao-Qi Xu, Jin-Wei Shi, Bai-Ling Chen, and Zili Chen . N2-Selective Iodofunctionalization of Olefins with NH-1,2,3-Triazoles to provide N2-Alkyl-Substituted 1,2,3-Triazoles. The Journal of Organic Chemistry 2016, 81 (9) , 3568-3575. https://doi.org/10.1021/acs.joc.6b00185
    29. Anthony J. Roecker, Christopher D. Cox, and Paul J. Coleman . Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia. Journal of Medicinal Chemistry 2016, 59 (2) , 504-530. https://doi.org/10.1021/acs.jmedchem.5b00832
    30. Debra J. Wallace Ian Mangion Paul Coleman . Discovery and Chemical Development of Suvorexant - A Dual Orexin Antagonist for Sleep Disorder. 2016, 1-36. https://doi.org/10.1021/bk-2016-1239.ch001
    31. Takashi Nagahara, Tsuyoshi Saitoh, Noriki Kutsumura, Yoko Irukayama-Tomobe, Yasuhiro Ogawa, Daisuke Kuroda, Hiroaki Gouda, Hidetoshi Kumagai, Hideaki Fujii, Masashi Yanagisawa, and Hiroshi Nagase . Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists. Journal of Medicinal Chemistry 2015, 58 (20) , 7931-7937. https://doi.org/10.1021/acs.jmedchem.5b00988
    32. Michael A. Letavic, Pascal Bonaventure, Nicholas I. Carruthers, Christine Dugovic, Tatiana Koudriakova, Brian Lord, Timothy W. Lovenberg, Kiev S. Ly, Neelakandha S. Mani, Diane Nepomuceno, Daniel J. Pippel, Michele Rizzolio, Jonathan E. Shelton, Chandra R. Shah, Brock T. Shireman, Lana K. Young, and Sujin Yun . Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate. Journal of Medicinal Chemistry 2015, 58 (14) , 5620-5636. https://doi.org/10.1021/acs.jmedchem.5b00742
    33. Yu Yoshida, Yoshimitsu Naoe, Taro Terauchi, Fumihiro Ozaki, Takashi Doko, Ayumi Takemura, Toshiaki Tanaka, Keiichi Sorimachi, Carsten T. Beuckmann, Michiyuki Suzuki, Takashi Ueno, Shunsuke Ozaki, and Masahiro Yonaga . Discovery of (1R,2S)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide (E2006): A Potent and Efficacious Oral Orexin Receptor Antagonist. Journal of Medicinal Chemistry 2015, 58 (11) , 4648-4664. https://doi.org/10.1021/acs.jmedchem.5b00217
    34. Ananya Srivastava, Leena Aggarwal, and Nidhi Jain . One-Pot Sequential Alkynylation and Cycloaddition: Regioselective Construction and Biological Evaluation of Novel Benzoxazole–Triazole Derivatives. ACS Combinatorial Science 2015, 17 (1) , 39-48. https://doi.org/10.1021/co500135z
    35. John Y. L. Chung, Yong-Li Zhong, Kevin M. Maloney, Robert A. Reamer, Jeffrey C. Moore, Hallena Strotman, Alexei Kalinin, Ronnie Feng, Neil A. Strotman, Bangping Xiang, and Nobuyoshi Yasuda . Unusual Pyrimidine Participation: Efficient Stereoselective Synthesis of Potent Dual Orexin Receptor Antagonist MK-6096. Organic Letters 2014, 16 (22) , 5890-5893. https://doi.org/10.1021/ol5028249
    36. Alexander Heifetz, Oliver Barker, G. Benjamin Morris, Richard J. Law, Mark Slack, and Philip C. Biggin . Toward an Understanding of Agonist Binding to Human Orexin-1 and Orexin-2 Receptors with G-Protein-Coupled Receptor Modeling and Site-Directed Mutagenesis. Biochemistry 2013, 52 (46) , 8246-8260. https://doi.org/10.1021/bi401119m
    37. Claudia Betschart, Samuel Hintermann, Dirk Behnke, Simona Cotesta, Markus Fendt, Christine E. Gee, Laura H. Jacobson, Grit Laue, Silvio Ofner, Vinod Chaudhari, Sangamesh Badiger, Chetan Pandit, Juergen Wagner, and Daniel Hoyer . Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia. Journal of Medicinal Chemistry 2013, 56 (19) , 7590-7607. https://doi.org/10.1021/jm4007627
    38. Bifu Liu, Meizhou Yin, Hanling Gao, Wanqing Wu, and Huanfeng Jiang . Synthesis of 2-Aminobenzoxazoles and 3-Aminobenzoxazines via Palladium-Catalyzed Aerobic Oxidation of o-Aminophenols with Isocyanides. The Journal of Organic Chemistry 2013, 78 (7) , 3009-3020. https://doi.org/10.1021/jo400002f
    39. Mélina Girardin, Stéphane G. Ouellet, Danny Gauvreau, Jeffrey C. Moore, Greg Hughes, Paul N. Devine, Paul D. O’Shea, and Louis-Charles Campeau . Convergent Kilogram-Scale Synthesis of Dual Orexin Receptor Antagonist. Organic Process Research & Development 2013, 17 (1) , 61-68. https://doi.org/10.1021/op3002678
    40. Corey R. Hopkins . ACS Chemical Neuroscience Molecule Spotlight on Suvorexant. ACS Chemical Neuroscience 2012, 3 (9) , 647-648. https://doi.org/10.1021/cn300086a
    41. Ian K. Mangion, Benjamin D. Sherry, Jingjun Yin, and Fred J. Fleitz . Enantioselective Synthesis of a Dual Orexin Receptor Antagonist. Organic Letters 2012, 14 (13) , 3458-3461. https://doi.org/10.1021/ol3014123
    42. Murali Mohan Guru and Tharmalingam Punniyamurthy . Copper(II)-Catalyzed Aerobic Oxidative Synthesis of Substituted 1,2,3- and 1,2,4-Triazoles from Bisarylhydrazones via C–H Functionalization/C–C/N–N/C–N Bonds Formation. The Journal of Organic Chemistry 2012, 77 (11) , 5063-5073. https://doi.org/10.1021/jo300592t
    43. Neil A. Strotman, Carl A. Baxter, Karel M. J. Brands, Ed Cleator, Shane W. Krska, Robert A. Reamer, Debra J. Wallace, and Timothy J. Wright . Reaction Development and Mechanistic Study of a Ruthenium Catalyzed Intramolecular Asymmetric Reductive Amination en Route to the Dual Orexin Inhibitor Suvorexant (MK-4305). Journal of the American Chemical Society 2011, 133 (21) , 8362-8371. https://doi.org/10.1021/ja202358f
    44. Carl A. Baxter, Ed Cleator, Karel M. J. Brands, John S. Edwards, Robert A. Reamer, Faye J. Sheen, Gavin W. Stewart, Neil A. Strotman, and Debra J. Wallace . The First Large-Scale Synthesis of MK-4305: A Dual Orexin Receptor Antagonist for the Treatment of Sleep Disorder. Organic Process Research & Development 2011, 15 (2) , 367-375. https://doi.org/10.1021/op1002853
    45. Christopher L. Cioffi, John J. Lansing, and Hamza Yüksel. Synthesis of 2-Aminobenzoxazoles Using Tetramethyl Orthocarbonate or 1,1-Dichlorodiphenoxymethane. The Journal of Organic Chemistry 2010, 75 (22) , 7942-7945. https://doi.org/10.1021/jo1017052
    46. Fernanda Majolo, Lavynia Ferreira Hoffmann, Wilian Luan Pilatti Sant’Ana, Celso Alves, Joana Silva, Alice Martins, Rui Pedrosa, Bruno Dahmer, Guilherme Liberato da Silva, Luís Fernando Saraiva Macedo Timmers, Márcia Inês Goettert. Recent Drugs Tested in Clinical Trials for Alzheimer´s and Parkinson´s Diseases Treatment: Current Approaches in Tracking New Drugs. 2024, 1-58. https://doi.org/10.2174/9789815179842124120003
    47. Koushik Mondal, Payel Ghosh, Alakananda Hajra. An Electrochemical Oxo‐amination of 2 H ‐Indazoles: Synthesis of Symmetrical and Unsymmetrical Indazolylindazolones. Chemistry – A European Journal 2024, 30 (12) https://doi.org/10.1002/chem.202303890
    48. Ihori Kobayashi, Patrick A. Forcelli. The effects of a dual orexin receptor antagonist on fear extinction memory and sleep in mice: Implications for exposure therapy. Behavioural Brain Research 2024, 458 , 114741. https://doi.org/10.1016/j.bbr.2023.114741
    49. Miklós Jászberényi, Balázs Thurzó, Zsolt Bagosi, László Vécsei, Masaru Tanaka. The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress. Biomedicines 2024, 12 (2) , 448. https://doi.org/10.3390/biomedicines12020448
    50. Christine Brotschi, Martin H. Bolli, John Gatfield, Catherine Roch, Thierry Sifferlen, Alexander Treiber, Jodi T. Williams, Christoph Boss. Pyrazole derivatives as selective orexin-2 receptor antagonists (2-SORA): synthesis, structure–activity–relationship, and sleep-promoting properties in rats. RSC Medicinal Chemistry 2024, 15 (1) , 344-354. https://doi.org/10.1039/D3MD00573A
    51. Ryan J. Keenan, Heather Daykin, Jeremy Metha, Linda Cornthwaite‐Duncan, David K. Wright, Kyra Clarke, Sara Oberrauch, Maddison Brian, Sarah Stephenson, Cameron J. Nowell, Giancarlo Allocca, Kevin J. Barnham, Daniel Hoyer, Laura H. Jacobson. Orexin 2 receptor antagonism sex‐dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice. British Journal of Pharmacology 2024, 181 (1) , 87-106. https://doi.org/10.1111/bph.16212
    52. Kayo Imamura, Ken-Ichi Akagi, Yohei Miyanoiri, Hirokazu Tsujimoto, Takatsugu Hirokawa, Hideo Ashida, Kaori Murakami, Asuka Inoue, Ryoji Suno, Takahisa Ikegami, Naotaka Sekiyama, So Iwata, Takuya Kobayashi, Hidehito Tochio. Interaction modes of human orexin 2 receptor with selective and nonselective antagonists studied by NMR spectroscopy. Structure 2024, 128 https://doi.org/10.1016/j.str.2023.12.008
    53. Christopher Daniel Morrone, Radha Raghuraman, S. Abid Hussaini, Wai Haung Yu. Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer’s disease. Molecular Neurodegeneration 2023, 18 (1) https://doi.org/10.1186/s13024-023-00617-4
    54. Clemens Muehlan, Catherine Roch, Cedric Vaillant, Jasper Dingemanse. The orexin story and orexin receptor antagonists for the treatment of insomnia. Journal of Sleep Research 2023, 32 (6) https://doi.org/10.1111/jsr.13902
    55. Jessica M. Illenberger, Francisco J. Flores-Ramirez, Glenn Pascasio, Alessandra Matzeu, Rémi Martin-Fardon. Daily treatment with the dual orexin receptor antagonist DORA-12 during oxycodone abstinence decreases oxycodone conditioned reinstatement. Neuropharmacology 2023, 239 , 109685. https://doi.org/10.1016/j.neuropharm.2023.109685
    56. Philipp Kohler, Ivan Schindelholz, Gabriel Schäfer. Scalable, Chromatography‐Free Synthesis of 2‐(3‐Bromophenyl)‐2 H ‐1,2,3‐triazole through N−N Bond Forming Cyclization. Helvetica Chimica Acta 2023, 106 (10) https://doi.org/10.1002/hlca.202300146
    57. Tsuyoshi Saitoh, Takeshi Sakurai. The present and future of synthetic orexin receptor agonists. Peptides 2023, 167 , 171051. https://doi.org/10.1016/j.peptides.2023.171051
    58. Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, Alessandro Piergentili, Elizabeth Saab, Luca Botticelli, Carlo Cifani, Emanuela Micioni Di Bonaventura, Maria Vittoria Micioni Di Bonaventura, Wilma Quaglia. Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders. Medicinal Research Reviews 2023, 43 (5) , 1607-1667. https://doi.org/10.1002/med.21959
    59. Kihang Choi. The Structure-property Relationships of GPCR-targeted Drugs Approved between 2011 and 2021. Current Medicinal Chemistry 2023, 30 (31) , 3527-3549. https://doi.org/10.2174/1573399819666221102113217
    60. Gavin P. Schmitz, Bryan L. Roth. G protein-coupled receptors as targets for transformative neuropsychiatric therapeutics. American Journal of Physiology-Cell Physiology 2023, 325 (1) , C17-C28. https://doi.org/10.1152/ajpcell.00397.2022
    61. Pilar Marcos, Rafael Coveñas. Involvement of the Orexinergic System in Cancer: Antitumor Strategies and Future Perspectives. Applied Sciences 2023, 13 (13) , 7596. https://doi.org/10.3390/app13137596
    62. Mohammad Sheibani, Maryam Shayan, Mina Khalilzadeh, Mehdi Ghasemi, Ahmad Reza Dehpour. Orexin receptor antagonists in the pathophysiology and treatment of sleep disorders and epilepsy. Neuropeptides 2023, 99 , 102335. https://doi.org/10.1016/j.npep.2023.102335
    63. Alexander Treiber, Hamed Aissaoui, Stéphane Delahaye, Sven Glutz, Julien Grimont, Claus Müller, Swen Seeland, Valérie Siefken, Christoph Boss. CYP3A4 Catalyzes the Rearrangement of the Dual Orexin Receptor Antagonist Daridorexant to 4‐Hydroxypiperidinol Metabolites. ChemMedChem 2023, 18 (10) https://doi.org/10.1002/cmdc.202300030
    64. Nikita E. Safronov, Artem S. Minin, Pavel A. Slepukhin, Irena P. Kostova, Enrico Benassi, Nataliya P. Belskaya. 5-Amino-2-aryl-2H-1,2,3-triazole-4-carboxamides: Unique AIEE-gens and selective Hg2+ fluorosensors. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2023, 292 , 122419. https://doi.org/10.1016/j.saa.2023.122419
    65. Jessica M. Illenberger, Francisco J. Flores-Ramirez, Alessandra Matzeu, Barbara J. Mason, Rémi Martin-Fardon. Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats. Frontiers in Pharmacology 2023, 14 https://doi.org/10.3389/fphar.2023.1127735
    66. Yang Lin, Koustav Roy, Shuji Ioka, Rintaro Otani, Mao Amezawa, Yukiko Ishikawa, Yoan Cherasse, Mahesh K. Kaushik, Daniela Klewe-Nebenius, Li Zhou, Masashi Yanagisawa, Yo Oishi, Tsuyoshi Saitoh, Michael Lazarus. Positive allosteric adenosine A2A receptor modulation suppresses insomnia associated with mania- and schizophrenia-like behaviors in mice. Frontiers in Pharmacology 2023, 14 https://doi.org/10.3389/fphar.2023.1138666
    67. Alexander Treiber, Stephane Delahaye, Aude Weigel, Päivi Aeänismaa, John Gatfield, Swen Seeland. The metabolism of the dual orexin receptor antagonist daridorexant. Xenobiotica 2023, 53 (3) , 173-183. https://doi.org/10.1080/00498254.2023.2183159
    68. Neha, Suhel Parvez. Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer’s disease. Ageing Research Reviews 2023, 85 , 101815. https://doi.org/10.1016/j.arr.2022.101815
    69. Ruwaida Ben Musa, Jennifer Cornelius-Green, Eileen M. Hasser, Kevin J. Cummings. The effect of orexin on the hypoxic ventilatory response of female rats is greatest in the active phase during diestrus. Journal of Applied Physiology 2023, 134 (3) , 638-648. https://doi.org/10.1152/japplphysiol.00661.2022
    70. Venkata Ramana Murthy Appala, Kanaka Durga Bhavani Anagani, Aparna Pasula. Synthesis of New Piperidine based N(2)-Alkylated 1,2,3-Triazole Hybrids in Basic Medium. Asian Journal of Chemistry 2023, 35 (1) , 212-216. https://doi.org/10.14233/ajchem.2023.26906
    71. Tony Fleischer, Gabriel Schäfer. Large‐Scale Synthesis of 4‐Methyl‐2‐(2 H ‐1,2,3‐triazol‐2‐yl)benzoic Acid – A Key Fragment of Single Orexin Receptor Antagonist ACT‐539313 – through Cu 2 O‐Catalyzed, Ligand‐Free Ullmann–Goldberg Coupling. Helvetica Chimica Acta 2023, 106 (1) https://doi.org/10.1002/hlca.202200162
    72. Francisco J. Flores-Ramirez, Jessica M. Illenberger, Glenn E. Pascasio, Alessandra Matzeu, Barbara J. Mason, Rémi Martin-Fardon. Alternative use of suvorexant (Belsomra®) for the prevention of alcohol drinking and seeking in rats with a history of alcohol dependence. Frontiers in Behavioral Neuroscience 2022, 16 https://doi.org/10.3389/fnbeh.2022.1085882
    73. Habibolah Khazaie, Masoud Sadeghi, Sepideh Khazaie, Max Hirshkowitz, Amir Sharafkhaneh. Dual orexin receptor antagonists for treatment of insomnia: A systematic review and meta-analysis on randomized, double-blind, placebo-controlled trials of suvorexant and lemborexant. Frontiers in Psychiatry 2022, 13 https://doi.org/10.3389/fpsyt.2022.1070522
    74. Adrienn G. Varga, Jessica R. Whitaker-Fornek, Sebastian N. Maletz, Erica S. Levitt. Activation of orexin-2 receptors in the Kӧlliker-Fuse nucleus of anesthetized mice leads to transient slowing of respiratory rate. Frontiers in Physiology 2022, 13 https://doi.org/10.3389/fphys.2022.977569
    75. Marie Pardon, Pieter Claes, Sarah Druwé, Murielle Martini, Aleksandra Siekierska, Christel Menet, Peter A. M. de Witte, Daniëlle Copmans. Modulation of sleep behavior in zebrafish larvae by pharmacological targeting of the orexin receptor. Frontiers in Pharmacology 2022, 13 https://doi.org/10.3389/fphar.2022.1012622
    76. Menglin Chen, Zhengrong Zhu, Tom Wisniewski, Xiaoping Zhang, David G. McLaren, Adam Weinglass, S. Adrian Saldanha. Label-free LC-MS based assay to characterize small molecule compound binding to cells. SLAS Discovery 2022, 27 (7) , 405-412. https://doi.org/10.1016/j.slasd.2022.08.005
    77. Xin Wu, Tao Xue, Zhouqing Chen, Zhong Wang, Gang Chen. Orexin Receptor Antagonists and Insomnia. Current Psychiatry Reports 2022, 24 (10) , 509-521. https://doi.org/10.1007/s11920-022-01357-w
    78. Tsuyoshi Saitoh, Mao Amezawa, Jumpei Horiuchi, Yasuyuki Nagumo, Naoshi Yamamoto, Noriki Kutsumura, Ryuichiro Ohshita, Akihisa Tokuda, Yoko Irukayama-Tomobe, Yasuhiro Ogawa, Yukiko Ishikawa, Emi Hasegawa, Takeshi Sakurai, Yasuo Uchida, Tetsu Sato, Hiroaki Gouda, Ryuji Tanimura, Masashi Yanagisawa, Hiroshi Nagase. Discovery of novel orexin receptor antagonists using a 1,3,5-trioxazatriquinane bearing multiple effective residues (TriMER) library. European Journal of Medicinal Chemistry 2022, 240 , 114505. https://doi.org/10.1016/j.ejmech.2022.114505
    79. Jagrut A. Shah, Ming‐Yu Ngai. (Hetero)Aryl CH Amination via Organic Electrochemistry. 2022, 1-46. https://doi.org/10.1002/9783527834242.chf0066
    80. Alain Couvineau, Pascal Nicole, Valérie Gratio, Thierry Voisin. The Orexin receptors: Structural and anti-tumoral properties. Frontiers in Endocrinology 2022, 13 https://doi.org/10.3389/fendo.2022.931970
    81. Fillan S. Grady, Aaron D. Boes, Joel C. Geerling. A Century Searching for the Neurons Necessary for Wakefulness. Frontiers in Neuroscience 2022, 16 https://doi.org/10.3389/fnins.2022.930514
    82. Makoto Uchiyama, Daiji Kambe, Yumiko Imadera, Yu Kajiyama, Hiroki Ogo, Naohisa Uchimura. Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study. Psychopharmacology 2022, 239 (7) , 2143-2154. https://doi.org/10.1007/s00213-022-06089-6
    83. Ryan J. Keenan, Heather Daykin, Jiahui Chu, Linda Cornthwaite‐Duncan, Giancarlo Allocca, Daniel Hoyer, Laura H. Jacobson. Differential sleep/wake response and sex differences following acute suvorexant, MK‐1064 and zolpidem administration in the rTg4510 mouse model of tauopathy. British Journal of Pharmacology 2022, 179 (13) , 3403-3417. https://doi.org/10.1111/bph.15813
    84. Md Tarikul Islam, Florian Rumpf, Yusuke Tsuno, Shota Kodani, Takeshi Sakurai, Ayako Matsui, Takashi Maejima, Michihiro Mieda. Vasopressin neurons in the paraventricular hypothalamus promote wakefulness via lateral hypothalamic orexin neurons. Current Biology 2022, 93 https://doi.org/10.1016/j.cub.2022.07.020
    85. Richard L. Spinieli, Ruwaida Ben Musa, Jennifer Cornelius-Green, Eileen M. Hasser, Kevin J. Cummings. Orexin facilitates the ventilatory and behavioral responses of rats to hypoxia. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2022, 322 (6) , R581-R596. https://doi.org/10.1152/ajpregu.00334.2021
    86. Wojciech Zawodny, Sarah Louise Montgomery. Evolving New Chemistry: Biocatalysis for the Synthesis of Amine-Containing Pharmaceuticals. Catalysts 2022, 12 (6) , 595. https://doi.org/10.3390/catal12060595
    87. Eduarda M. P. Silva, Pedro A. M. M. Varandas, Artur M. S. Silva. 1,4‐Diazepane Ring‐Based Systems. 2022, 559-584. https://doi.org/10.1002/9781119757153.ch17
    88. Lipeng Long, Jieyan Wang, Xin Li, ShunFeng Peng, Liang Qiao, Guotian Luo, Zhengwang Chen. Hypervalent iodine( iii ) promoted tandem reaction of o -fluoroanilines with formamides to construct 2-aminobenzoxazoles. Organic Chemistry Frontiers 2022, 9 (9) , 2412-2417. https://doi.org/10.1039/D2QO00049K
    89. Laura H. Jacobson, Daniel Hoyer, Luis de Lecea. Hypocretins (orexins): The ultimate translational neuropeptides. Journal of Internal Medicine 2022, 291 (5) , 533-556. https://doi.org/10.1111/joim.13406
    90. Natasha C. Dale, Daniel Hoyer, Laura H. Jacobson, Kevin D. G. Pfleger, Elizabeth K. M. Johnstone. Orexin Signaling: A Complex, Multifaceted Process. Frontiers in Cellular Neuroscience 2022, 16 https://doi.org/10.3389/fncel.2022.812359
    91. Debashis Ghosh, Sumit Ghosh, Anogh Ghosh, Pranjal Pyne, Souvik Majumder, Alakananda Hajra. Visible light-induced functionalization of indazole and pyrazole: a recent update. Chemical Communications 2022, 58 (28) , 4435-4455. https://doi.org/10.1039/D2CC00002D
    92. Carlos Pérez‐Martín, Francisca Rebolledo, Rosario Brieva. Amine Transaminase Mediated Synthesis of Optically Pure Piperazinones and 1,4‐Diazepanones. Advanced Synthesis & Catalysis 2022, 364 (7) , 1326-1336. https://doi.org/10.1002/adsc.202101510
    93. Arthur A. DeCarlo, Nathan Hammes, Philip L. Johnson, Anantha Shekhar, Brian C. Samuels. Dual Orexin Receptor Antagonist Attenuates Increases in IOP, ICP, and Translaminar Pressure Difference After Stimulation of the Hypothalamus in Rats. Investigative Opthalmology & Visual Science 2022, 63 (3) , 1. https://doi.org/10.1167/iovs.63.3.1
    94. Tsubasa Hino, Tsuyoshi Saitoh, Yasuyuki Nagumo, Naoshi Yamamoto, Noriki Kutsumura, Yoko Irukayama-Tomobe, Yukiko Ishikawa, Ryuji Tanimura, Masashi Yanagisawa, Hiroshi Nagase. Design and synthesis of novel orexin 2 receptor agonists based on naphthalene skeleton. Bioorganic & Medicinal Chemistry Letters 2022, 59 , 128530. https://doi.org/10.1016/j.bmcl.2022.128530
    95. Gilles Ouvry. Recent applications of seven-membered rings in drug design. Bioorganic & Medicinal Chemistry 2022, 57 , 116650. https://doi.org/10.1016/j.bmc.2022.116650
    96. Yanhui Guo, Yunyun Liu, Jie-Ping Wan. Amine-catalyzed synthesis of N2-sulfonyl 1,2,3-triazole in water and the tunable N2-H 1,2,3-triazole synthesis in DMSO via metal-free enamine annulation. Chinese Chemical Letters 2022, 33 (2) , 855-858. https://doi.org/10.1016/j.cclet.2021.08.003
    97. Cong Guan, Jian Ji, Zi Li, Qinghua Wei, Xiang Wu, Shunying Liu. Facile synthesis of N2-substituted-1,2,3-triazole from aryl ethynylene and azide via a one-pot two-step strategy. Tetrahedron 2022, 108 , 132670. https://doi.org/10.1016/j.tet.2022.132670
    98. Hiroki Kawashima, Yuri Aono, Yuriko Watanabe, John L. Waddington, Tadashi Saigusa. In vivo microdialysis reveals that blockade of accumbal orexin OX 2 but not OX 1 receptors enhances dopamine efflux in the nucleus accumbens of freely moving rats. European Journal of Neuroscience 2022, 55 (3) , 733-745. https://doi.org/10.1111/ejn.15593
    99. Vishakha Rai, Kavyashree P., Sarvesh S. Harmalkar, Sundar N. Dhuri, Mahagundappa R. Maddani. 1,6-Addition of 1,2,3-NH triazoles to para -quinone methides: Facile access to highly selective N 1 and N 2 substituted triazoles. Organic & Biomolecular Chemistry 2022, 20 (2) , 345-351. https://doi.org/10.1039/D1OB01717A
    100. Safoor Fathima, Sireesha Murala, Pradeep C. Bollu. Orexins. 2022, 181-209. https://doi.org/10.1007/978-3-031-07897-2_10
    Load more citations

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    MENDELEY PAIRING EXPIRED
    Your Mendeley pairing has expired. Please reconnect